Tanaka, A. et al. 2024. Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis. Acta Dermato-Venereologica. 104, (Sep. 2024), adv34375. DOI:https://doi.org/10.2340/actadv.v104.34375.